Carl Zeiss Meditec AG announced that, after securing all required regulatory approvals, it has completed the acquisition of 100% of D.O.R.C. (Dutch Ophthalmic Research Center) from the investment firm Eurazeo SE, Paris, France.
The Swiss lens manufacturer Optiswiss has appointed Frederik Zimmermann to a key position to strengthen its international brand presence. Since March 2024, Frederik Zimmermann has been part of Optiswiss AG as Head of Global Expansion.
Vision Expo East 2024 concluded on Sunday, March 17, following three days of new product discovery, innovative discussions, accredited education sessions, networking events and business meetings. Celebrating nearly 40 years at the Jacob Javits Center in New York City March 14–17, Vision Expo East convened thousands of eyecare professionals, buyers, students, and sellers representing all…
Horizons Optical and Oakley Capital, the leading pan-European, mid-market private equity investor, announced that Oakley Capital Origin Fund I is investing in Horizons Optical.
In January 2024, Ultra Optics, a global leader in spin coating equipment and lacquers, became a member of the Satisloh Group. Ultra Optics products will be available through Satisloh around the world with a gradual roll-out beginning in the Americas.
The Opticians Association of America (OAA), and the National Federation of Opticianry Schools (NFOS), have completed a merger. The new organization will be named United Opticians Association (UOA).
After a successful launch in 2023 with over 250 international and local brands from 15 countries attracting 2175 trade visitors, Silmo Singapore returns with a new edition from 24 to 26 April 2024 at the Suntec Exhibition and Convention Centre.
New report reveals diverse eyewear preferences and purchase behaviors, unveiling opportunities for optical industry growth.
The Vision Council and RX, co-organizers of Vision Expo, shared details on Vision Expo East’s official opening night party and other special events planned during the multi-day, must-attend meeting taking place at the Javits Center in New York City for one final show before moving to Orlando, Florida, in 2025.
SightGlass Vision, a joint venture of CooperCompanies and EssilorLuxottica, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to its Diffusion Optics Technology (DOT) spectacle lenses, which are intended to slow myopia progression in children.
